Epigenetic regulation in neurodevelopment and neurodegenerative diseases
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
From fertilization throughout development and until death, cellular programs in individual cells are dynamically regulated to fulfill multiple functions ranging from cell lineage specification to adaptation to internal and external stimuli. Such regulation is of major importance in brain cells, because the brain continues to develop long after birth and incorporates information from the environment across life. When compromised, these regulatory mechanisms can have detrimental consequences on neurodevelopment and lead to severe brain pathologies and neurodegenerative diseases in the adult individual. Elucidating these processes is essential to better understand their implication in disease etiology. Because they are strongly influenced by environmental factors, they have been postulated to depend on epigenetic mechanisms. This review describes recent studies that have identified epigenetic dysfunctions in the pathophysiology of several neurodevelopmental and neurodegenerative diseases. It discusses currently known pathways and molecular targets implicated in pathologies including imprinting disorders, Rett syndrome, and Alzheimer's, Parkinson's and Hungtinton's disease, and their relevance to these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
Amir, R. E., Van den Veyver, I. B., Wan, M., Tran, C. Q., Francke, U., & Zoghbi, H. Y. (1999) · Nature Genetics · doi:10.1038/13810 · Cited by 4,990 · cited 1×
“Rett syndrome is an X-linked neurological disorder with early onset (18 months) that affects one girl in 10,000–15,000 (Amir et al., 1999).”
BackgroundGenome-wide maps of chromatin state in pluripotent and lineage-committed cells
Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T.-K., Koche, R. P., et al. (2007) · Nature · doi:10.1038/nature06008 · Cited by 4,129 · cited 1×
“Neuroscience (2013), 2007; Mikkelsen et al., 2007; Burgold et al., 2008).”
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Adult Neurogenesis in the Mammalian Brain: Significant Answers and Significant Questions
Ming, G.-L., & Song, H. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.001 · Cited by 2,651 · cited 1×
“The role of adult neurogenesis in brain functions remains unclear and somewhat controversial, but evidence has suggested that it is important for memory processes, and may be implicated in psychiatric and neurological disorders such as depression, addiction and epilepsy (Ming and Song, 2011).”
BackgroundGenomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“For instance, DNA methyl-binding domain proteins (MBD1–4) and methyl-CpG binding protein 2 (MeCP2) are recruited to methylated DNA, and engage histone deacetylases (HDACs) complexes (Jones and Takai, 2001; Klose and Bird, 2006).”
BackgroundSpatio-temporal transcriptome of the human brain
Kang, H. J., Kawasawa, Y. I., Cheng, F., Zhu, Y., Xu, X., Li, M., Sousa, A. M. M., Pletikos, M., Meyer, K. A., Sedmak, G., et al. (2011) · Nature · doi:10.1038/nature10523 · Cited by 2,084 · cited 1×
“In human, many genes important for fundamental neuronal functions such as synaptic plasticity, transport of vesicles and mitochondrial functions are downregulated in the cerebral cortex after the age of 40 (Lu et al., 2004; Yankner et al., 2008; Kang et al., 2011; Wood et al., 2012).”
BackgroundGene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription
Chahrour, M., Jung, S. Y., Shaw, C., Zhou, X., Wong, S. T. C., Qin, J., & Zoghbi, H. Y. (2008) · Science · doi:10.1126/science.1153252 · Cited by 1,823
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome
Guy, J., Hendrich, B., Holmes, M., Martin, J. E., & Bird, A. (2001) · Nature Genetics · doi:10.1038/85899 · Cited by 1,558
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation
Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G., & Sun, Y. E. (2003) · Science · doi:10.1126/science.1090842 · Cited by 1,405 · cited 5×
“In nonpathological conditions, MeCP2 at methylated DNA recruits HDAC1 (Martinowich et al., 2003; Klose and Bird, 2004) which leads to H3 and H4 hypoacetylation, and activation of H3K9 methylating enzymes (Fuks et al.”
BackgroundInfluentialEpigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327 · cited 1×
“Ultimately, a better profiling of epigenetic alterations in patients may provide new options for potential diagnostic use and for the development of epigenetic drug treatment (Arrowsmith et al., 2012).”
BackgroundDeficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice
Chen, R. Z., Akbarian, S., Tudor, M., & Jaenisch, R. (2001) · Nature Genetics · doi:10.1038/85906 · Cited by 1,275 · cited 4×
“…a primary role of MeCP2, most models have lower brain weight, smaller neurons, and reduced synaptic plasticity and display cognitive deficits and altered exploratory activity (Chen et al., 2001; Guy et al., 2001; Samaco et al., 2013) (Collins et al., 2004; Blackman et al., 2012; Li et al., 2012).”
BackgroundInfluentialThe Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 2×
“It is known that a tight regulation of MeCP2 expression is essential for proper neurodevelopment, and both MeCP2 over- and underexpression lead to neurodevelopmental defects (Collins et al., 2004; Chahrour and Zoghbi, 2007).”
BackgroundDerepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2
Chen, W. G., Chang, Q., Lin, Y., Meissner, A., West, A. E., Griffith, E. C., Jaenisch, R., & Greenberg, M. E. (2003) · Science · doi:10.1126/science.1086446 · Cited by 1,232
Reversal of Neurological Defects in a Mouse Model of Rett Syndrome
Guy, J., Gan, J., Selfridge, J., Cobb, S., & Bird, A. (2007) · Science · doi:10.1126/science.1138389 · Cited by 1,230 · cited 2×
“, 2004), confirming the direct implication of MeCP2 (Guy et al., 2007; Tropea et al., 2009).”
BackgroundRecovery of learning and memory is associated with chromatin remodelling
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L.-H. (2007) · Nature · doi:10.1038/nature05772 · Cited by 1,227 · cited 2×
“Treatment with HDAC inhibitors restores acetylation (H3K4), and rescues memory deficits and synaptic connectivity alterations in this mouse model of AD (Fischer et al., 2007; Francis et al., 2009), consistent with the implication of protein acetylation.”
BackgroundCharting histone modifications and the functional organization of mammalian genomes
Zhou, V. W., Goren, A., & Bernstein, B. E. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2905 · Cited by 1,147 · cited 8×
“During the switch to glial fate, GFAP expression in astrocytes is facilitated by recruitment of the HAT CBP to STAT3-binding element in the GFAP promoter (Takizawa et al., 2001).”
BackgroundInfluentialKim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601758 · Cited by 1,074 · cited 1×
“Consistently, overexpression of the HDAC SIRT1 produces neuroprotection in a mouse model of AD (Kim et al., 2007).”
BackgroundDnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons
Feng, J., Zhou, Y., Campbell, S. L., Le, T., Li, E., Sweatt, J. D., Silva, A. J., & Fan, G. (2010) · Nature Neuroscience · doi:10.1038/nn.2514 · Cited by 1,019
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes
Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 979 · cited 2×
“Htt also directly interacts with neuronrestrictive silencer factor (NRSF) and prevents its translocation to the nucleus (Zuccato et al., 2003).”
BackgroundAltered Histone Acetylation Is Associated with Age-Dependent Memory Impairment in Mice
Peleg, S., Sananbenesi, F., Zovoilis, A., Burkhardt, S., Bahari-Javan, S., Agis-Balboa, R. C., Cota, P., Wittnam, J. L., Gogol-Doering, A., Opitz, L., et al. (2010) · Science · doi:10.1126/science.1186088 · Cited by 951 · cited 1×
“…is increased at the promoter and intra-genic regions of IEGs such as the activity-dependent cytoskeleton-associated protein (Arc), a gene necessary for memory processes, and is associated with reduced gene expression and memory deficits in aged mice (Rowe et al., 2007b; Penner et al., 2011).”
BackgroundZhou, Z., Hong, E. J., Cohen, S., Zhao, W.-N., Ho, H.-Y. H., Schmidt, L., Chen, W. G., Lin, Y., Savner, E., Griffith, E. C., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.037 · Cited by 877 · cited 1×
“Further, MeCP2 phosphorylation also alters the expression of genes involved in development, dendritic growth and spine maturation (Zhou et al., 2006; Smrt et al., 2007; Chahrour et al., 2008).”
BackgroundBurns, A., & Iliffe, S. (2009) · BMJ · doi:10.1136/bmj.b158 · Cited by 859
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772 · cited 1×
“They are caused primarily by the accumulation of extracellular plaques of amyloid-b (Ab) peptide produced from the altered processing of the amyloid precursor protein (APP), and neurofibrillary tangles containing hyperphosphorylated tau protein (Crews and Masliah, 2010; Niedowicz et al., 2011).”
BackgroundUncovering the role of 5-hydroxymethylcytosine in the epigenome
Branco, M. R., Ficz, G., & Reik, W. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3080 · Cited by 766 · cited 5×
“In a Rett mouse model, MeCP2 deficiency was associated with a dysregulation of miRNAs, and a severe disruption of miRNAs expression in the brain.”
BackgroundInfluentialNon-coding RNAs as regulators of gene expression and epigenetics
Kaikkonen, M. U., Lam, M. T. Y., & Glass, C. K. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr097 · Cited by 764 · cited 5×
“In a Rett mouse model, MeCP2 deficiency was associated with a dysregulation of miRNAs, and a severe disruption of miRNAs expression in the brain.”
BackgroundInfluentialSaura, C. A., Choi, S.-Y., Beglopoulos, V., Malkani, S., Zhang, D., Rao, B. S. S., Chattarji, S., Kelleher, R. J., Kandel, E. R., Duff, K., et al. (2004) · Neuron · doi:10.1016/s0896-6273(04)00182-5 · Cited by 757 · cited 1×
“These alterations are accompanied by impaired synaptic plasticity and memory formation (Saura et al., 2004).”
BackgroundYankner, B. A., Lu, T., & Loerch, P. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.2.010506.092044 · Cited by 677 · cited 1×
“In human, many genes important for fundamental neuronal functions such as synaptic plasticity, transport of vesicles and mitochondrial functions are downregulated in the cerebral cortex after the age of 40 (Lu et al., 2004; Yankner et al., 2008; Kang et al., 2011; Wood et al., 2012).”
BackgroundDavies, M. N., Volta, M., Pidsley, R., Lunnon, K., Dixit, A., Lovestone, S., Coarfa, C., Harris, R. A., Milosavljevic, A., Troakes, C., et al. (2012) · Genome Biology · doi:10.1186/gb-2012-13-6-r43 · Cited by 630
Mild overexpression of MeCP2 causes a progressive neurological disorder in mice
Collins, A. L., Levenson, J. M., Vilaythong, A. P., Richman, R., Armstrong, D. L., Noebels, J. L., David Sweatt, J., & Zoghbi, H. Y. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh282 · Cited by 626
Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes
Wu, H., Coskun, V., Tao, J., Xie, W., Ge, W., Yoshikawa, K., Li, E., Zhang, Y., & Sun, Y. E. (2010) · Science · doi:10.1126/science.1190485 · Cited by 604 · cited 2×
“040 to neurogenesis and synaptic plasticity in adult neurons (Feng et al., 2010; Wu et al., 2010).”
BackgroundInfluentialPartial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice
Tropea, D., Giacometti, E., Wilson, N. R., Beard, C., McCurry, C., Fu, D. D., Flannery, R., Jaenisch, R., & Sur, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812394106 · Cited by 593 · cited 2×
“, 2004), confirming the direct implication of MeCP2 (Guy et al., 2007; Tropea et al., 2009).”
BackgroundBlalock, E. M., Chen, K.-C., Sharrow, K., Herman, J. P., Porter, N. M., Foster, T. C., & Landfield, P. W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03807.2003 · Cited by 570 · cited 2×
“This has been correlated with increased DNA methylation (Blalock et al., 2003; Rowe et al., 2007a), particularly at genes involved in DNA binding, morphogenesis, and transcriptional regulation (Siegmund et al., 2007; Hernandez et al., 2011).”
BackgroundA role for glia in the progression of Rett’s syndrome
Lioy, D. T., Garg, S. K., Monaghan, C. E., Raber, J., Foust, K. D., Kaspar, B. K., Hirrlinger, P. G., Kirchhoff, F., Bissonnette, J. M., Ballas, N., et al. (2011) · Nature · doi:10.1038/nature10214 · Cited by 496 · cited 1×
“Further, although the Rett syndrome has been mainly associated with MeCP2 disruption in neurons (Chen et al., 2001), its alteration in glial cells and in the periphery has also been implicated (Ballas et al., 2009; Maezawa et al., 2009) (Lioy et al., 2011).”
BackgroundCross talk between microRNA and epigenetic regulation in adult neurogenesis
Szulwach, K. E., Li, X., Smrt, R. D., Li, Y., Luo, Y., Lin, L., Santistevan, N. J., Li, W., Zhao, X., & Jin, P. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200908151 · Cited by 493
Corepressor-Dependent Silencing of Chromosomal Regions Encoding Neuronal Genes
Lunyak, V. V., Burgess, R., Prefontaine, G. G., Nelson, C., Sze, S.-H., Chenoweth, J., Schwartz, P., Pevzner, P. A., Glass, C., Mandel, G., et al. (2002) · Science · doi:10.1126/science.1076469 · Cited by 472 · cited 1×
“This is in part achieved by DNA methylation of neuronrestrictive silencer element (NRSE) in the promoter region of genes such as sodium channel type II, BDNF or calbindin (Lunyak et al., 2002; Ballas et al., 2005).”
BackgroundNon–cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology
Ballas, N., Lioy, D. T., Grunseich, C., & Mandel, G. (2009) · Nature Neuroscience · doi:10.1038/nn.2275 · Cited by 466
The epigenetic effects of butyrate: potential therapeutic implications for clinical practice
Berni Canani, R., Di Costanzo, M., & Leone, L. (2012) · Clinical Epigenetics · doi:10.1186/1868-7083-4-4 · Cited by 431 · cited 2×
“Treatment with HDAC inhibitors have yielded promising initial results in mouse models of HD, providing neuronal protection by correcting general mRNA abnormalities through the modification of histones (Sadri-Vakili et al., 2007; Berni Canani et al., 2012).”
BackgroundFabel, K. (2009) · Frontiers in Neuroscience · doi:10.3389/neuro.22.002.2009 · Cited by 429 · cited 1×
“It can also be increased by physical exercise and enriched environment (Fabel et al., 2009; Wolf et al., 2011), in particular in aged mice.”
BackgroundCruchaga, C., Chakraverty, S., Mayo, K., Vallania, F. L. M., Mitra, R. D., Faber, K., Williamson, J., Bird, T., Diaz-Arrastia, R., Foroud, T. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031039 · Cited by 320
Critical loss of CBP/p300 histone acetylase activity by caspase‐6 during neurodegeneration
Rouaux, C., Jokic, N., Mbebi, C., Boutillier, S., Loeffler, J., & Boutillier, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg615 · Cited by 302
Cohen, S., Gabel, H. W., Hemberg, M., Hutchinson, A. N., Sadacca, L. A., Ebert, D. H., Harmin, D. A., Greenberg, R. S., Verdine, V. K., Zhou, Z., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.08.022 · Cited by 298 · cited 1×
“Disruption of MeCP2 phosphorylation alters synapse development and behavioral response (Cohen et al., 2011).”
Mouse models of MeCP2 disorders share gene expression changes in the cerebellum and hypothalamus
Ben-Shachar, S., Chahrour, M., Thaller, C., Shaw, C. A., & Zoghbi, H. Y. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp181 · Cited by 253
Mecp2 deficiency leads to delayed maturation and altered gene expression in hippocampal neurons
Smrt, R. D., Eaves-Egenes, J., Barkho, B. Z., Santistevan, N. J., Zhao, C., Aimone, J. B., Gage, F. H., & Zhao, X. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.005 · Cited by 239 · cited 1×
“Further, MeCP2 phosphorylation also alters the expression of genes involved in development, dendritic growth and spine maturation (Zhou et al., 2006; Smrt et al., 2007; Chahrour et al., 2008).”
BackgroundVilleneuve, L. M., Kato, M., Reddy, M. A., Wang, M., Lanting, L., & Natarajan, R. (2010) · Diabetes · doi:10.2337/db10-0208 · Cited by 186 · cited 1×
“Further, how environmental conditions can allow cellular systems to acquire specific features such as resistance to stress, and keep these features throughout life is also still poorly understood (Villeneuve et al., 2010, 2011).”
BackgroundHutnick, L. K., Golshani, P., Namihira, M., Xue, Z., Matynia, A., Yang, X. W., Silva, A. J., Schweizer, F. E., & Fan, G. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp222 · Cited by 181 · cited 2×
“Studies in DNMT1deficient cortical neurons have shown that a lack of DNMT1 alters neuronal excitability, increases neuronal cell death (Hutnick et al., 2009) and in neuronal stem cells (NSCs), compromises astrocytic differentiation (Fan et al., 2005).”
BackgroundMajor depression, cognitive dysfunction and Alzheimer's disease: Is there a link?
Sierksma, A. S. R., van den Hove, D. L. A., Steinbusch, H. W. M., & Prickaerts, J. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.021 · Cited by 139
Wood, S. H., Craig, T., Li, Y., Merry, B., & de Magalhães, J. P. (2013) · AGE · doi:10.1007/s11357-012-9410-1 · Cited by 105
Cited by
Lacampagne, A., Liu, X., Reiken, S., Bussiere, R., Meli, A. C., Lauritzen, I., Teich, A. F., Zalk, R., Saint, N., Arancio, O., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1733-7 · Cited by 181
Labouesse, M. A., Dong, E., Grayson, D. R., Guidotti, A., & Meyer, U. (2015) · Epigenetics · doi:10.1080/15592294.2015.1114202 · Cited by 138
“Such attempts, however, have been proven useful in other preclinical models relevant to schizophrenia, including pharmacological models and models of prenatal stress exposure.(74,78-80) The GAD1 promoter region seems particularly sensitive to epigenetic-based pharmacotherapy, as supported by previous work using DNMT o…”
BackgroundGapp, K., von Ziegler, L., Tweedie‐Cullen, R. Y., & Mansuy, I. M. (2014) · BioEssays · doi:10.1002/bies.201300116 · Cited by 136
Self-citationStrong, E., Butcher, D. T., Singhania, R., Mervis, C. B., Morris, C. A., De Carvalho, D., Weksberg, R., & Osborne, L. R. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.05.019 · Cited by 71
“Epigenetic modifications can be tissue specific and extremely dynamic, and they play key roles in the development of the mammalian nervous system.(18) Of the 25 genes commonly deleted or duplicated inWS or Dup7, respectively, six genes and their encoded proteins have been associated with”
BackgroundLi, X., Zhao, Q., Wei, W., Lin, Q., Magnan, C., Emami, M. R., Wearick-Silva, L. E., Viola, T. W., Marshall, P. R., Yin, J., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0339-x · Cited by 71
Metadata
- Authors
- Gapp, K., Woldemichael, B. T., Bohacek, J., & Mansuy, I. M.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 264
- Pages
- 99-111
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W1989942360
- Cited by
- 104
- References
- 48
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.